Literature DB >> 22372584

A retrospective study of diabetic foot ulcers treated with hyperbaric oxygen therapy.

Alexandra J Bishop1, Elizabeth Mudge.   

Abstract

A retrospective review of patient medical records was conducted to assess what factors influence the outcomes of diabetic foot ulcers treated with hyperbaric oxygen (HBO) therapy. Patients referred to the Diving Diseases Research Centre for HBO therapy for the treatment of diabetic foot ulcers during a 2-year period were included in this study. Data collected from 30 sets of patient records were entered into SPSS and statistical analysis was undertaken to investigate whether any underlying pathologies or confounding factors appeared to influence patient outcome. A 73.3% of patients achieved a successful outcome of partial healing, major amputation no longer required, amputation level lower than anticipated prior to HBO or healing at the end of HBO therapy and 70% remained successful 3 months later. A 13.3% of patients were lost to follow-up at 3 months and one patient (3.3%) had a major amputation. Steroid therapy, peripheral vascular disease, previous minor amputation, type of diabetes, previous HBO therapy, larvae therapy, the use of interactive dressings and haemoglobin A1c levels were all observed to have had a significant relationship with patient outcome (P < 0.05). These results were compared with data from other published research conducted in this area on similar patient groups. A larger scale study focussing on the factors found to be significant in this study is recommended. An improvement of patient documentation would allow patient outcomes to be more consistently monitored in the future.
© 2012 The Authors. © 2012 Blackwell Publishing Ltd and Medicalhelplines.com Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22372584      PMCID: PMC7950693          DOI: 10.1111/j.1742-481X.2011.00936.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  34 in total

1.  Effects of hyperoxia on neutrophil adhesion.

Authors:  S R Thom
Journal:  Undersea Hyperb Med       Date:  2004       Impact factor: 0.698

2.  Hyperbaric oxygen exposure improves blood glucose level and muscle oxidative capacity in rats with type 2 diabetes.

Authors:  Ning Gu; Fumiko Nagatomo; Hidemi Fujino; Isao Takeda; Kinsuke Tsuda; Akihiko Ishihara
Journal:  Diabetes Technol Ther       Date:  2010-02       Impact factor: 6.118

3.  Lower extremity minor amputations: the roles of diabetes mellitus and timing of revascularization.

Authors:  Malachi G Sheahan; Allen D Hamdan; Jennifer R Veraldi; Claudie S McArthur; John J Skillman; David R Campbell; Sherry D Scovell; Frank W Logerfo; Frank B Pomposelli
Journal:  J Vasc Surg       Date:  2005-09       Impact factor: 4.268

Review 4.  Hyperbaric oxygen therapy for chronic wounds.

Authors:  Peter Kranke; Michael H Bennett; Marrissa Martyn-St James; Alexander Schnabel; Sebastian E Debus; Stephanie Weibel
Journal:  Cochrane Database Syst Rev       Date:  2015-06-24

5.  Classification of diabetic foot wounds.

Authors:  L A Lavery; D G Armstrong; L B Harkless
Journal:  J Foot Ankle Surg       Date:  1996 Nov-Dec       Impact factor: 1.286

6.  Effects of smoking on cost and duration of hyperbaric oxygen therapy for diabetic patients with non-healing wounds.

Authors:  G H Otto; C Buyukcakir; C E Fife
Journal:  Undersea Hyperb Med       Date:  2000       Impact factor: 0.698

7.  Retrospective study of factors affecting non-healing of wounds during hyperbaric oxygen therapy.

Authors:  C M Oubre; A Roy; C Toner; J Kalns
Journal:  J Wound Care       Date:  2007-06       Impact factor: 2.072

8.  Hyperbaric oxygen in diabetic gangrene treatment.

Authors:  G Baroni; T Porro; E Faglia; G Pizzi; A Mastropasqua; G Oriani; G Pedesini; F Favales
Journal:  Diabetes Care       Date:  1987 Jan-Feb       Impact factor: 19.112

9.  Hyperbaric oxygen therapy in diabetic foot.

Authors:  N Doctor; S Pandya; A Supe
Journal:  J Postgrad Med       Date:  1992 Jul-Sep       Impact factor: 1.476

10.  Factors influencing the outcome of lower-extremity diabetic ulcers treated with hyperbaric oxygen therapy.

Authors:  Caroline E Fife; Cem Buyukcakir; Gordon Otto; Paul Sheffield; Tommy Love; Robert Warriner
Journal:  Wound Repair Regen       Date:  2007 May-Jun       Impact factor: 3.617

View more
  7 in total

Review 1.  Platelet-rich plasma and the elimination of neuropathic pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2013-07-07       Impact factor: 5.590

2.  Hyperbaric oxygen preconditioning protects skin from UV-A damage.

Authors:  Ashley M Fuller; Charles Giardina; Lawrence E Hightower; George A Perdrizet; Cassandra A Tierney
Journal:  Cell Stress Chaperones       Date:  2012-08-03       Impact factor: 3.667

3.  High glucose improves healing of periodontal wound by inhibiting proliferation and osteogenetic differentiation of human PDL cells.

Authors:  Min Li; Cheng-Zhang Li
Journal:  Int Wound J       Date:  2014-02-28       Impact factor: 3.315

4.  Hyperbaric oxygen therapy (HBOT) suppresses biomarkers of cell stress and kidney injury in diabetic mice.

Authors:  Rajeev Verma; Avijeet Chopra; Charles Giardina; Venkata Sabbisetti; Joan A Smyth; Lawrence E Hightower; George A Perdrizet
Journal:  Cell Stress Chaperones       Date:  2015-02-04       Impact factor: 3.667

5.  Comparison of simultaneous systemic steroid and hyperbaric oxygen treatment versus only steroid in idiopathic sudden sensorineural hearing loss.

Authors:  Elif Ersoy Callioglu; Arzu Tuzuner; Sule Demirci; Ceyhun Cengiz; Refik Caylan
Journal:  Int J Clin Exp Med       Date:  2015-06-15

6.  PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts.

Authors:  Mogher Khamaisi; Sayaka Katagiri; Hillary Keenan; Kyoungmin Park; Yasutaka Maeda; Qian Li; Weier Qi; Thomas Thomou; Danielle Eschuk; Ana Tellechea; Aris Veves; Chenyu Huang; Dennis Paul Orgill; Amy Wagers; George L King
Journal:  J Clin Invest       Date:  2016-01-25       Impact factor: 14.808

7.  Hyperbaric oxygen therapy for nonischemic diabetic ulcers: A systematic review.

Authors:  Rutger C Lalieu; Robin J Brouwer; Dirk T Ubbink; Rigo Hoencamp; René Bol Raap; Rob A van Hulst
Journal:  Wound Repair Regen       Date:  2019-11-26       Impact factor: 3.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.